Delivery Order SPE2DB20D1047-SPE2DB25FF72H
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,040.63 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100s, a pharmaceutical product used for malaria prophylaxis and treatment. The contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100-count units) valued at $2,350.53 under a firm fixed price contract. This antimalarial pharmaceutical product is being delivered to support military healthcare requirements, with the place of performance located in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $22,857.87 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count). This competitive, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 21, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. The medication is an...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,245.97 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 (100 tablets), a antimalarial medication used primarily for malaria prophylaxis and treatment in military personnel. The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, under firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,718.44 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The work will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,343.16 to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. The contract, which is firm fixed price with an ultimate completion date of April 24, 2025, carries no set-aside designation and was competitively awarded. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $14,922.01 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 tablets) on September 12, 2025, with a completion date of September 15, 2025. This is a firm fixed price order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $3,273.76 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 100S, a combination antimalarial medication. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 16, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $33,579 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 in a quantity of 100 units. The contract, which was competitively awarded without set-aside designation, has an ultimate completion date of September 17, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $4,599.31 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets in quantities of 100. This is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and was competitively awarded. This delivery order is issued under AmerisourceBergen...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF72HDelivery Order
The Defense Logistics Agency awarded a $16,299.47 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100, a combination antimalarial medication supplied in a 100-count format. Awarded on July 16, 2025, with an ultimate completion date of July 17, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency, military, and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This specific delivery order for antimalarial medication supports the military's medical supply chain requirements and reflects AmerisourceBergen's established track record of meeting federal procurement standards through competitive contracting processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 7/16/25 |